OncoMed Pharmaceuticals Stock Predictions

NASDAQ Stock Exchange

Open Broker Account

$0.89

+0 (+0%)

At Close: Sep 17, 2019

Currently predicting for Mon, 6 May 2024

OMED Predictions History

5 years ago
NameNotImportant predicted that OMED for 2019-04-22 is going $1.06 (12.78%)

6 years ago
Victor..Li.8930 predicted that OMED for 2017-08-21 is going $4.17 (-1.88%)

About OncoMed Pharmaceuticals

OncoMed Pharmaceuticals, Inc., a clinical development-stage biopharmaceutical company, discovers and develops novel anti-cancer stem cell (CSC) and immuno-oncology therapeutics. The companys product candidates and preclinical programs include demcizumab (anti-DLL4, OMP-21M18), a humanized monoclonal antibody, which is in two Phase II clinical trials for non-small cell lung cancer and pancreatic cancer patients; tarextumab (anti-Notch2/3, OMP-59... OMED Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

OncoMed Pharmaceuticals Stock Predictions

OMED Predictions History

About OncoMed Pharmaceuticals

Golden Star

Top Fintech Company